Kathryn G. Roberts

St. Jude Children's Research Hospital — United States

Medicine · Health Sciences

55h-index14.0kcitations310works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(215), Chronic Myeloid Leukemia Treatments(87), Acute Myeloid Leukemia Research(61), Childhood Cancer Survivors' Quality of Life(49), Chronic Lymphocytic Leukemia Research(47)

Publications308 total

Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial
Blood·2025Open Access
Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing
UNC Libraries·2025Open Access
Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis
Genome Medicine·2025· 3 citedOpen Access
Establishing Normative Measurements and Ratios for Rotator Cuff Muscles in a Military Population Using Diagnostic Ultrasound
2025Open Access
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Leukemia·2025· 6 citedOpen Access
Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis
2024· 2 citedOpen Access
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
2024· 3 citedOpen Access
Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with <i>BCR::ABL1</i> Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial
Blood·2024
Assessment of Outcomes of Allogeneic Stem Cell Transplantation By Treatment Arm in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia Randomized to Conventional Chemotherapy +/- Blinatumomab in the ECOG-ACRIN E1910 Phase III National Clinical Trials Network Trial
Blood·2024· 2 citedOpen Access
Revolutionizing B-ALL Cell Line Development: Novel Generation to Uncover Therapeutic Vulnerabilities
Blood·2024Open Access
Data from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
Supplementary Tables from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
Supplementary Note from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Methods from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Table S6 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Table S14 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Figure S3 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Table S15 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies &lt;i&gt;LMO2/STAG2&lt;/i&gt; Rearrangements as Extremely High Risk
2024Open Access
page 1 of 16Next →

Frequent Co-authors

Charles G. Mullighan(45), Stephen P. Hunger(21), Jinghui Zhang(20), Debbie Payne-Turner(20), Mignon L. Loh(20), Ching‐Hon Pui(20), Cheryl L. Willman(19), Richard C. Harvey(17), Deqing Pei(16), Jun J. Yang(16), William E. Evans(15), Mary V. Relling(15), Elisabeth Paietta(14), Cheng Cheng(13), Meenakshi Devidas(13), James R. Downing(13), Zhaohui Gu(13), Gang Wu(12), Sima Jeha(12), William L. Carroll(11)